Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy)

Journal:
American Journal of Respiratory and Critical Care Medicine
Published:
DOI:
10.1093/ajrccm/aamag215
Affiliations:
3
Authors:
5
Go to article
Institutions Authors Share
Apnimed, Inc., United States of America (USA)
3.000000
 0.60
University of Pittsburgh (Pitt), United States of America (USA)
1.500000
 0.30
VA Pittsburgh Healthcare System, United States of America (USA)
0.500000
 0.10
Interested in Cardiovascular Medicine and Haematology?